MEN syndrome is an umbrella term used to describe a family of tumor syndromes ultimately characterized by histologically similar tumors arising in patients and families with mutations in one of four genes: MEN1, RET, CDKN1B, and MAX. Here, CDKN1B is linked to multiple endocrine neoplasia.